Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Cosmo Pharmaceuticals NV
SIX:CMHC
Cosmo Pharmaceuticals NV
SIX:CMHC
Price:
53.2
CHF
0.57%
Market Closed
Market Cap:
CHf933.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cosmo Pharmaceuticals NV
SIX:CMHC
|
IE |
Wall St Price Targets
CMHC Price Forecast
Based on 8 analysts
Based on 8 analysts
+120% Upside
from
CHf53.2
today
Cosmo Pharmaceuticals NV (CMHC)’s 12-month stock price forecast through October 2027 has a consensus target of CHf117.3, implying 120% upside. The forecast is based on price targets from 8 Wall Street analysts.
CMHC Analyst Rating
No ratings yet
No ratings yet
Cosmo Pharmaceuticals NV Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CMHC's stock price target?
Price Target
117.3
CHF
117.3
CHF
According to Wall Street analysts, the average 1-year price target for CMHC is 117.3 CHF with a low forecast of 80.8 CHF and a high forecast of 168 CHF.
What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
38%
38%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 38%.
What is the Gross Profit forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
44%
44%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 44%.